We demonstrate a compact implantable intraocular pressure sensor with remote optical readout for glaucoma research and patient management. Using broadband white light between 780-1150nm, we excite the sensor's pressure-sensitive optomechanical cavity and detect the reflected light, whose optical signature changes as a function of intraocular pressure. When measured inside an artificial pressure chamber that emulates the anterior chamber of the eye, the sensor provided robust measurements of hydrostatic pressures between 10-60 mmHg with an accuracy of 0.15 mmHg and a linearity of 0.97.
INTRODUCTION
Glaucoma is a leading cause of blindness, affecting an estimated 4 million Americans and 70 million individuals globally [1] . As glaucoma typically affects the elderly, the aging demographic trends indicate that this disease will continue to be an ever-increasing socioeconomic burden to society [1] [2] [3] [4] . Elevated intraocular pressure (IOP) is a major risk factor for glaucoma, and IOP monitoring is the single most important clinical management tool [2] . Despite the pervasive use of IOP readings for disease monitoring, and the clinically proven importance of the aggressive lowering of IOP [5] [6] [7] [8] [9] [10] , current clinical management is primarily based on only periodic snapshots of IOP in the doctor's office obtained every few months based on indirect measurements [11] [12] . The inability of patients to easily monitor their own IOPs at different times of the day or during various daily activities, hinder the comprehensive understanding of the IOP profile of individual patients [13] and the possibility of custom-tailored IOP control. In addition to its use as a patient monitoring parameter, IOP is also the standard readout used in glaucoma research. However, achieving an acceptable level of accuracy and repeatability in animal-IOP measurements requires anesthesia and extreme care [14] [15] . Conducting such time-consuming measurements in large populations of animals is a major hurdle in glaucoma drug discovery. The need for better IOP monitoring in clinical ophthalmology and in disease research has been widely appreciated, and a number of efforts have been made to develop MEMS-based implantable sensors [16] [17] [18] . However, these implants are too large (diameter: 1-3 mm) for use in rodent models (corneal diameter ~ 3.5 mm), which make up > 90% of the animal species used in glaucoma research. Sensor implants with such dimensions may also interfere with normal human ocular function and be cosmetically and psychologically unacceptable to patients.
We are developing a highly miniaturized IOP monitoring system using a nanophotonics-based implantable IOP sensor with remote optical readout that can be adapted for both patient and small animal research use. The device's operating principle and configuration are shown in Figures1 and Figure 2 , respectively. A remote detector optically excites the pressure-sensitive nanophotonic structure of the IOP-sensing implant placed in the anterior chamber and detects the reflected light, whose optical signature changes as a function of IOP. Optical detection eliminates the need for large, complex inductivecoupling or capacitive-sensing (LC) structures [16] [17] and simplifies sensor design. In addition, readout involves 780-1150nm light that is not sensed by the photosensitive neurons in the retina.
The use of precisely engineered nanophotonic components improves the sensor's resolution and sensitivity, increases optical readout distance, and reduces its size by a factor of 10-30 (ultimately down to 50 µm in diameter and 25 µm in height) over previously reported implants. Its small size and convenient optical readout will allow more frequent and accurate self-tracking of IOP by patients in home settings. In addition, this technology can be adapted for use in automatically monitoring large cohorts of animals to support glaucoma research and drug discovery. 
DEVICE DESIGN Operating Principle
The core of the device, the optomechanical cavity, is formed by a flexible 3-µm Parylene membrane with a diameter of 200 µm (the deformable part) [16] [17] and a rigid silicon substrate on the bottom,
as shown in Figure 2 . Both the Parylene and silicon surfaces are embedded with resonance-enhancing 50×50-µm 2 gold nanodot arrays with the dot-to-dot pitch of 1000 nm and the nanodot diameter of 800 nm. These values were experimentally determined for the sensor's optimal performance and are discussed in more detail below. As the pressure increases from 1 atm, the initial 2-µm gap between the Parylene membrane and the silicon (Si) substrate decreases, and this decrease in the gap shifts the resonant wavelength of the cavity (Fig. 1) .
Optomechanical Simulation and Design
To design a pressure sensor that exhibits highly linear mapping between spectral resonance shifts and pressure changes, we ran a series of optomechanical finite-element-method (FEM) and finitedifference-time-domain (FDTD) simulations using commercial programs (COMSOL and CST), in combination with experimental measurements.
We first determined the spectral range for pressure sensing. The wavelength range of interest is between 770 and 1100 nm because the light absorption in water and tissues would be minimal in this range, facilitating the penetration through the cornea and the aqueous humor. In addition, this wavelength range is not sensed by photoreceptor cells in the retina. We set the initial cavity gap at 2 µm, which is a gap value that can readily be microfabricated. Using FDTD simulation, we first identified a free spectral range of the sensor cavity for clear detection of the resonance shift, as shown in The simulation results have indicated that the free spectral range exists between 780 and 900 nm, which would allow a shift range of 120 nm, when the gap decreases by 400 nm, from 2 µm to 1.6 µm. Next, using FEM simulation, we designed the Parylene membrane -its diameter and thickness -so that it would deflect 400 nm in response to the change in the ambient pressure (ie. IOP) of 40 mmHg between 10 and 50 mmHg. Based on our simulation results, the diameter and the thickness of the Parylene membrane were determined to be 100 µm and 3 µm.
Resonance-Enhancing Nanodot Arrays
The resonance strength and properties of a Fabry-Perot optical cavity are heavily influenced by the reflectivity at the cavity ends. If the reflectivity is high, the resonance becomes very narrow and sharp, and the quality factor of the resonance increases. However, in this case, the overall amplitude (peak-to-valley height) of the resonance, which directly translates to the signal-to-noise ratio for sensing application, significantly decreases. On the other hand, if the reflectivity is low, the resonance becomes very broad and its amplitude also becomes smaller, making it difficult to detect the resonance. This tradeoff is clearly illustrated by the blue line (from simulation) in Figure 5 . Very high or low reflectivity results in low resonance amplitude or peak-to-valley height.
An optimal reflectivity exists around 0.6  0.2, where the peak-to-valley height is maximized.
Figure 4: a) FEM simulation of a Parylene membrane deformation as a function of hydrostatic ambient pressure change. b) Linear mapping between "the membrane deflection vs. the spectral shift." c) Linear mapping between "the membrane deflection vs. the intraocular pressure change." For 1 mmHg change, the membrane deforms by 10 nm, and this results in 3nm shift in resonance or 3nm
spectral shift per 1mmHg pressure change.
Figure 5: Measured P-V ratios vs. nanodot diameters: The optimal diameter ranges between 700 and 850 nm.
Hence, we use engineered gold nanodot arrays to optimize the reflectivity of the Parylene membrane surface and the silicon surface. In order to adjust reflectivity of a membrane using nanodot arrays, we only need to vary the diameter and pitch of the nanodots, which can be accomplished precisely and repeatedly using an electron-beam lithography system. Consequently, compared to using other coating techniques, the placement of gold nanodots allows us to control Parylene membrane reflectivity in a more reliable and repeatable manner. To find an optimal diameter, we fabricated a series of nanodot arrays with varying diameters from 500 to 850 nm while keeping the pitch at 1000 nm and experimentally measured their reflectivities.
Fitting the experimentally obtained reflectivities onto the simulation curve as shown in Figure 5 , we found that the optimal nanodot diameter was 750 nm. To keep our nanofabrication parameters simple, we chose 800 nm for the nanodot diameter.
DEVICE FABRICATION
The proposed device is fabricated on a silicon wafer using microscale and nanoscale fabrication techniques. To fabricate the sensor, we first performed photolithography and deep reactive ion etching (DRIE) to create a 2-µm-deep cavity chamber and a recess (for adhesive) in the Si wafer (Figure 6a) . Then, we patterned a 170-nm-thick gold nanodot array on the Si substrate using e-beam lithography, gold evaporation, and lift-off (Figure 6b) . Next, using DRIE, we created four air holes on the front side of the wafer and on the air reserve chamber on the back of the wafer (Figure 6c) . During the etching process, the air reserve chamber eventually reached the air holes, and they all become connected. Then we patterned another gold nanodot array on the Parylene membrane (Figure 6d ) using e-beam lithography, gold evaporation, and lift-off. Next, using epoxy, we assembled the Parylene membrane and the Si substrate while keeping their nanodot arrays aligned to each other under the optical microscope (Figure 6e ). Finally we completely sealed the air reserve chamber using epoxy and a Si chip (Figure 6f ). The photos of the completed device, including the SEM image of the gold nanodot, are shown in Figure 7 . The requirement on alignment accuracy between the two gold nanodot arrays, one on the Parylene membrane and the other on the silicon substrate, is lenient. The maximum misalignment shown in Figure 7b is about 4 m, and the size of the resulting active sensing area is 85% of the designed value, which can easily accommodate the probing beam and would not degrade the performance of the sensor. 
DEVICE MEASUREMENTS
We tested the completed devices inside a water-filled pressure chamber that emulated the anterior chamber of the human eyes (Figure 8 ). The artificial chamber has a transparent window on the top for optical measurements, and its internal pressure can be precisely adjusted using an external regulator and simultaneously monitored using a digital pressure gauge (model name: DPGWB-04; manufacturer: Dwyer Instruments, INC.; accuracy: ±0.5%; thermal effect: 0.05%). Using a broadband source (model name: OSL1 High-Intensity Fiber Light Source; manufacturer: Thorlabs) and a commercially available mini-spectrometer (Maya 2000Pro by Ocean Optics; 0.22-nm spectral resolution), we remotely acquired the reflection spectra from the sensor in the chamber at a distance of 7 mm ( Figure 8 ). As we linearly increased the chamber pressure from 10 to 60 mmHg and tracked the locations of the major peaks in the spectra, we observed that the spectra shifted to the shorter wavelengths, as shown in Figure 9 . The average values and standard deviation of the peak locations were determined from over 300 measurements. The mapping between the pressure changes and the resonance shifts was highly linear as shown in Figure 10 , with a linear fit of 0.966. The sensitivity and the accuracy of the pressure sensor were 1.53 nm/mmHg and 0.15 mmHg over the range of 10-60 mmHg. The mini-spectrophotometer with 0.22nm spectral resolution was used reliably to resolve 1.53nm change in resonance shift per 1 mmHg change in pressure. When compared to the sensor without gold nanodot arrays, the presence of the nanodot array significantly enhanced the signal-to-noise ratio of the sensor by a factor of seven and enabled more robust remote detection. Following the successful measurements in the artificial pressure chamber, we pursued measurements in ex-vivo rabbit eyes. Figure  11 shows robust optical resonance captured remotely over a 7-mm distance from an earlier prototype device (consisting of two rigid membranes that do not flex) implanted in the anterior chamber of an ex-vivo rabbit eye and also in saline as a reference measurement. In both cases, we obtained consistent resonance peaks at identical locations. 
CONCLUSIONS
We have designed and fabricated a compact implantable IOP sensor with remote optical readout for glaucoma research and patient management. We have demonstrated its IOP-sensing capability between 10-60 mmHg in an artificial pressure chamber and captured the resonance spectrum from a prototype sensor implanted in the anterior chamber of an ex-vivo rabbit eye. We are presently working on (1) measurements in ex-vivo and in-vivo rabbit eyes; (2) further miniaturization of the implantable IOP sensors below 100 µm for use in rodent eyes; (3) a longer optical readout distance (theoretical limit ~ 20 cm); and (4) algorithms for automatic assignments of spectral shifts to pressure values. 
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